Biogen Inc.
US ˙ NasdaqGS ˙ US09062X1037

SecurityBIIB / Biogen Inc.
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership212,921 shares
Latest Disclosed Value $ 39,034,807
Qube Research & Technologies Ltd ownership in BIIB / Biogen Inc.

On May 15, 2026 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 212,921 shares of Biogen Inc. (US:BIIB) valued at $39,034,807 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 0 shares of Biogen Inc.. The current value of the position is $41,723,999 USD.

Qube Research & Technologies Ltd has a history of taking positions in derivatives of the underlying security (BIIB) in the form of stock options. The firm currently holds call options representing 15,800 of underlying shares valued at $2,896,614 USD and put options representing 6,600 of underlying shares valued at $1,209,978 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BIIB / Biogen Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOGEN COM 09062X103 212,921 212,921 39,035 0.0434
2026-02-17 2025-12-31 13F BIOGEN COM 09062X103 0 -121,607 -100.00 0 -100.00
2025-11-14 2025-09-30 13F BIOGEN COM 09062X103 121,607 -621,702 -83.64 17,035 -81.75 0.0176
2025-08-14 2025-06-30 13F BIOGEN COM 09062X103 743,309 -483,400 -39.41 93,352 -44.39 0.0949
2025-05-15 2025-03-31 13F BIOGEN COM 09062X103 1,226,709 135,867 12.46 167,863 0.63 0.1947
2025-02-14 2024-12-31 13F BIOGEN COM 09062X103 1,090,842 741,497 212.25 166,812 146.34 0.2187
2024-11-14 2024-09-30 13F BIOGEN COM 09062X103 349,345 335,113 2,354.64 67,717 1,952.65 0.0998
2024-08-14 2024-06-30 13F BIOGEN COM 09062X103 14,232 -86,613 -85.89 3,299 -84.83 0.0052
2024-05-14 2024-03-31 13F BIOGEN COM 09062X103 100,845 100,845 21,745 0.0345
2024-02-13 2023-12-31 13F BIOGEN COM 09062X103 0 -6,328 -100.00 0 -100.00
2023-11-13 2023-09-30 13F BIOGEN COM 09062X103 6,328 -42,041 -86.92 1,626 -88.20 0.0042
2023-08-14 2023-06-30 13F BIOGEN COM 09062X103 48,369 48,369 13,778 0.0501
2023-05-15 2023-03-31 13F BIOGEN COM 09062X103 0 -228,626 -100.00 0 -100.00
2023-02-14 2022-12-31 13F BIOGEN COM 09062X103 228,626 228,626 63,311 0.3389
2022-11-14 2022-09-30 13F BIOGEN COM 09062X103 0 -18,881 -100.00 0 -100.00
2022-08-15 2022-06-30 13F BIOGEN COM 09062X103 18,881 -143,066 -88.34 3,851 -88.71 0.0284
2022-05-09 2022-03-31 13F BIOGEN COM 09062X103 161,947 146,864 973.71 34,106 842.42 0.2890
2022-02-10 2021-12-31 13F/A-1 BIOGEN COM 09062X103 15,083 -44,123 -74.52 3,619 -78.40 0.0279
2022-02-01 2021-12-31 13F BIOGEN COM 09062X103 15,083 -44,123 3,619 0.0280
2021-11-12 2021-09-30 13F BIOGEN COM 09062X103 59,206 -17,445 -22.76 16,755 -36.87 0.2102
2021-08-13 2021-06-30 13F BIOGEN COM 09062X103 76,651 76,651 26,542 0.3024
2021-05-14 2021-03-31 13F BIOGEN COM 09062X103 0 -28,151 -100.00 0 -100.00
2021-02-16 2020-12-31 13F BIOGEN COM 09062X103 28,151 8,045 40.01 6,893 20.85 0.0980
2020-11-12 2020-09-30 13F BIOGEN COM 09062X103 20,106 -30,278 -60.09 5,704 -57.69 0.0814
2020-08-14 2020-06-30 13F BIOGEN COM 09062X103 50,384 47,076 1,423.10 13,480 1,187.49 0.1978
2020-05-15 2020-03-31 13F BIOGEN COM 09062X103 3,308 3,308 -93.43 1,047 -92.23 0.0430
2019-11-13 2019-09-30 13F BIOGEN COM 09062X103 0 -10,176 -100.00 0 -100.00
2019-08-02 2019-06-30 13F BIOGEN COM 09062X103 10,176 10,176 2,380 0.5666
2019-02-14 2018-12-31 13F BIOGEN COM 09062X103 0 -10,440 -100.00 0 -100.00
2018-11-14 2018-09-30 13F BIOGEN COM 09062X103 10,440 9,429 932.64 3,689 1,159.04 0.4904
2018-08-15 2018-06-30 13F/A-1 BIOGEN COM 09062X103 1,011 -237 -18.99 293 -14.08 0.1849
2018-08-14 2018-06-30 13F BIOGEN COM 09062X103 1,011 -237 293
2018-05-14 2018-03-31 13F BIOGEN COM 09062X103 1,248 1,248 341 0.1311
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BIOGEN COM Call 15,800 -78.12 2,897 -77.21 n/a n/a n/a
2026-02-17 2025-12-31 13F BIOGEN COM Call 72,200 -13.22 12,706 9.03 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOGEN COM Call 83,200 -19.61 11,655 -10.34 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOGEN COM Call 103,500 -5.82 12,999 -13.57 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOGEN COM Call 109,900 321.07 15,039 276.80 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOGEN COM Call 26,100 68.39 3,991 32.86 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOGEN COM Call 15,500 3,005 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOGEN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-14 2024-03-31 13F BIOGEN COM Call 100 22 n/a n/a n/a
2024-02-13 2023-12-31 13F BIOGEN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-13 2023-09-30 13F BIOGEN COM Call 18,300 4,703 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BIOGEN COM Put 6,600 -93.92 1,210 -93.67 n/a n/a n/a
2026-02-17 2025-12-31 13F BIOGEN COM Put 108,500 -13.96 19,095 8.10 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOGEN COM Put 126,100 -39.75 17,664 -32.80 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOGEN COM Put 209,300 -65.71 26,286 -68.53 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOGEN COM Put 610,300 81.21 83,513 62.15 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOGEN COM Put 336,800 414.98 51,503 306.27 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOGEN COM Put 65,400 -51.98 12,677 -59.85 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOGEN COM Put 136,200 673.86 31,574 731.96 n/a n/a n/a
2024-05-14 2024-03-31 13F BIOGEN COM Put 17,600 3,795 n/a n/a n/a
2024-02-13 2023-12-31 13F BIOGEN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-13 2023-09-30 13F BIOGEN COM Put 18,800 4,832 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.